Inventor
VENET MARC G
FR14 patents
⚠️ This page may combine multiple inventors who share the name “VENET MARC G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
13 patentsUS5037829AAug 6, 1991
(1H-azol-1-ylmethyl) substituted quinazoline derivatives
JANSSEN PHARMACEUTICA NV57 citations95
US5151421ASep 29, 1992
(1h-azol-1-ylmethyl) substituted quinoxaline derivatives
JANSSEN PHARMACEUTICA NV29 citations92
US5028606AJul 2, 1991
(1H-azol-1-ylmethyl)substituted quinoxaline derivatives
JANSSEN PHARMACEUTICA NV44 citations92
US4943574AJul 24, 1990
(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
JANSSEN PHARMACEUTICA NV23 citations89
US5612354AMar 18, 1997
(1H-azol-1-ylmethyl)substituted quinoline derivatives
JANSSEN PHARMACEUTICA NV13 citations73
US5039677AAug 13, 1991
6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
JANSSEN PHARMACEUTICA NV2 citations61
US5268380ADec 7, 1993
(1H-azol-1-ylmethyl) substituted quinoline derivatives
JANSSEN PHARMACEUTICA NV1 citations57
US5589484ADec 31, 1996
4-quinolinyl derivatives
JANSSEN PHARMACEUTICA NV4 citations52
US5441954AAug 15, 1995
(1h-azol-1-ylmethyl) substituted quinoline derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US5180832AJan 19, 1993
(3-pyridinyl)methanone oxime derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US4963573AOct 16, 1990
[[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
JANSSEN PHARMACEUTICA NV0 citations51
US4746671AMay 24, 1988
Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
JANSSEN PHARMACEUTICA NV1 citations51
US7407969B2Aug 5, 2008
Respiratory syncytial virus replication inhibitors
JANSSEN PHARMACEUTICA NV1 citations48